(ERF) Eurofins Scientific SE - Ratings and Ratios

Exchange: PA • Country: Luxembourg • Currency: EUR • Type: Common Stock • ISIN: FR0014000MR3

ERF: Testing, Analysis, Laboratory, Services, Chemistry, Biology

Eurofins Scientific SE (PA:ERF) stands as a leader in the global analytical testing and laboratory services sector, renowned for its comprehensive suite of services designed to ensure the safety, quality, and regulatory compliance of products across diverse industries. Established in 1987 and headquartered in Luxembourg, the company has carved a niche through its extensive

Additional Sources for ERF Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ERF Stock Overview

Market Cap in USD 9,913m
Sector Healthcare
Industry Diagnostics & Research
GiC Sub-Industry Biotechnology
IPO / Inception

ERF Stock Ratings

Growth 5y -21.8%
Fundamental 31.7%
Dividend 9.58%
Rel. Strength -5.02
Analysts -
Fair Price Momentum 43.30 EUR
Fair Price DCF 129.31 EUR

ERF Dividends

Dividend Yield 12m 1.00%
Yield on Cost 5y 1.26%
Annual Growth 5y -7.40%
Payout Consistency 76.6%

ERF Growth Ratios

Growth Correlation 3m 31.1%
Growth Correlation 12m -51.8%
Growth Correlation 5y -58.1%
CAGR 5y 4.10%
CAGR/Max DD 5y 0.06
Sharpe Ratio 12m 0.02
Alpha -26.05
Beta 0.713
Volatility 31.31%
Current Volume 439.7k
Average Volume 20d 435.8k
What is the price of ERF stocks?
As of April 02, 2025, the stock is trading at EUR 48.64 with a total of 439,699 shares traded.
Over the past week, the price has changed by -3.53%, over one month by -0.59%, over three months by -0.27% and over the past year by -18.02%.
Is Eurofins Scientific SE a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Eurofins Scientific SE is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 31.74 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ERF as of April 2025 is 43.30. This means that ERF is currently overvalued and has a potential downside of -10.98%.
Is ERF a buy, sell or hold?
Eurofins Scientific SE has no consensus analysts rating.
What are the forecast for ERF stock price target?
According to ValueRays Forecast Model, ERF Eurofins Scientific SE will be worth about 47.3 in April 2026. The stock is currently trading at 48.64. This means that the stock has a potential downside of -2.86%.
Issuer Forecast Upside
Wallstreet Target Price 58.1 19.4%
Analysts Target Price - -
ValueRay Target Price 47.3 -2.9%